Heart news and heart widget
Friday, November 21, 2008 ( change date )
Duska Therapeutics Applies For Phase 3 Special Protocol Assessment
Duska Therapeutics, Inc., (OTC Bulletin Board: DSKA), announced that it has submitted its pivotal Phase 3 ATPace clinical trial protocol for review under a Special Protocol Assessment (SPA) procedure with the U.S. Food and Drug Administration (FDA). Subject to securing an agreement with the FDA, Duska intends to initiate a single, prospective, double-blind, placebo-controlled and randomized Phase 3 clinical trial with its lead product ATPace.
Medicalnewstoday.com Friday, November 21, 2008Trellis(R) Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
Clinical data from a prospective registry presented this week at the 35th Annual Veith Symposium shows DVT treatment with the Trellis(R) Peripheral Infusion System from Bacchus Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most patients in about 20 minutes. This technique, called isolated pharmacomechanical thrombolysis, restores blood flow more quickly and safely than current catheter-directed thrombolysis (CDT) techniques.
Medicalnewstoday.com Friday, November 21, 2008Portuguese Scientists Discover New Mechanism That Regulates Formation Of Blood Vessels
Researchers in one of the external groups of the Instituto Gulbenkian de Ciência (IGC), in Portugal, have discovered a novel mechanism which regulates the process whereby new blood vessels are formed and wounds heal, including chronic wounds, such as those found in diabetic patients and those suffering from morbid obesity.
Medicalnewstoday.com Friday, November 21, 2008Aldagen Announces Positive Phase 1/2 Results For Critical Limb Ischemia Stem Cell Therapy ALD-301
Aldagen today announced positive results from its multicenter Phase 1/2 clinical trial of ALD-301, a novel stem cell therapy being developed for the treatment of critical limb ischemia. In the 24-week Phase 1/2 trial, ALD-301 was well tolerated.
Medicalnewstoday.com Friday, November 21, 2008Tracing Metal Pollution Back To Its Sources
A new way of pinpointing where zinc pollution in the atmosphere comes from could improve pollution monitoring and regulation, says research out this week in the journal Analytical Chemistry. Imperial College London researchers say their work is a major breakthrough as current methods for analysing zinc pollution only measure pollution in the atmosphere; they do not trace it back to its source.
Medicalnewstoday.com Friday, November 21, 2008Lowering Blood Pressure Pictures Slideshow: Exercise Tips for Getting Started
Title: Lowering Blood Pressure Pictures Slideshow: Exercise Tips for Getting StartedCategory: SlideshowsCreated: 11/19/2008Last Editorial review: 11/21/2008
medicinenet.com Friday, November 21, 2008Vitamin D Deficit Could Lead to Heart Woes
Title: Vitamin D Deficit Could Lead to Heart WoesCategory: health newscreated: 11/21/2008 2:00:00 amlast Editorial review: 11/21/2008
medicinenet.com Friday, November 21, 2008Parent Smoking During Pregnancy Raises Kids' Heart Risks
Title: Parent smoking During Pregnancy Raises Kids' Heart RisksCategory: health newscreated: 11/21/2008 2:00:00 amlast Editorial review: 11/21/2008
medicinenet.com Friday, November 21, 2008Specialized Stroke Care Improves Outcomes
Title: Specialized Stroke Care Improves OutcomesCategory: health newscreated: 11/21/2008 2:00:00 amlast Editorial review: 11/21/2008
MedicineNet Friday, November 21, 2008Cases of stroke complicating heart attack down (Reuters)
Reuters - While the incidence of stroke as a complication of heart attack has decreased since the late 1990s, death during hospitalization in affected patients has not shown a corresponding decrease, new data suggest.
yahoo.com Friday, November 21, 2008
PREVIEW
OF YOUR NEWS WIDGET
INSTALL YOUR WIDGET